Fortune Pharmacal is a finished-dose manufacturer based in Hong Kong. It appears in 42 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with DH (HK), NMPA (CN) and Health Canada. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 6 June 2025 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Hong Kong, Hong Kong | 3003952755 |
| Regulator | Filings | GMP certificates |
|---|---|---|
| DH (HK) | 37 | None |
| NMPA (CN) | 4 | None |
| Health Canada | 1 | None |
| US FDA | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Fortune Pharmacal comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.